Fetal first trimester growth is not associated with kidney outcomes in childhood

Hanneke Bakker1,2,3, Romy Gaillard1,2,3, Albert Hofman2,4

  • 1The Generation R Study Group (Na-29-15), Erasmus University Medical Center, Box 2040, 3000 CA, Rotterdam, The Netherlands.

Insights

First trimester fetal growth restriction did not significantly impact childhood kidney function. However, lower fetal growth was linked to larger kidney volume in children, suggesting further research into early life kidney development is needed.

Area of Science:

  • Perinatal epidemiology
  • Pediatric nephrology
  • Developmental origins of health and disease

Background:

  • Impaired fetal growth is a known risk factor for adult kidney disease.
  • The first trimester is a critical period for organ development, including kidneys.
  • Understanding early growth impacts on kidney health is crucial for long-term outcomes.

Purpose of the Study:

  • To investigate the association between fetal growth in the first trimester and kidney outcomes in childhood.
  • To determine if early fetal growth restriction influences kidney size and function during childhood.
  • To identify potential critical windows of development for kidney health.

Main Methods:

  • Prospective population-based cohort study of 1176 mother-child pairs.
  • Fetal first trimester crown-rump length used as the primary growth measure.
  • Childhood kidney volume, microalbuminuria, and estimated glomerular filtration rate (eGFR) assessed at median age 6 years.

Main Results:

  • No consistent associations were found between first trimester fetal growth and childhood eGFR or microalbuminuria.
  • Children in the lowest quintile of first trimester growth had significantly larger combined kidney volume compared to those in the highest quintile.
  • Despite differences in kidney size, childhood kidney function (eGFR) did not differ based on first trimester growth.

Conclusions:

  • The study does not support the hypothesis that first trimester fetal growth restriction directly impacts childhood kidney size and function.
  • While kidney volume may be affected, early fetal growth restriction does not appear to impair kidney function in early childhood.
  • Further research is warranted to explore other critical periods in early life that may influence long-term kidney health and disease risk.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
308
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
640